Validation of long-term benefits of bivalirudin versus unfractionated heparin in routine clinical practice after percutaneous coronary intervention

American Journal of Cardiology

Volumn 106, Issue 9, 2010, Pages 1234-1240

  Vidi, Venkatesan D ^a   Matheny, Michael E ^b,c   Agarwal, Vikram ^a   Arora, Nipun ^a   Donnelly, Sharon ^a   Bangalore, Sripal ^a   Resnic, Frederic S ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b Veterans Administration   (United States)

^c VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; GLYCOPROTEIN P INHIBITOR; HEMOGLOBIN; HEPARIN; HIRULOG;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BARE METAL STENT; BLEEDING; BLOOD CLOTTING TIME; CARDIAC PATIENT; CEREBROVASCULAR DISEASE; CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY OBSTRUCTION; DIABETES MELLITUS; DRUG ELUTING STENT; FEMALE; HEART FAILURE; HEMOGLOBIN BLOOD LEVEL; HOSPITAL DISCHARGE; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; KIDNEY FAILURE; LEFT CORONARY ARTERY; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; RADIAL ARTERY; RENAL REPLACEMENT THERAPY; ROTATIONAL ATHERECTOMY; SMOKING; STABLE ANGINA PECTORIS; THROMBUS; UNSTABLE ANGINA PECTORIS; VALIDATION STUDY; VASCULAR ACCESS;

AGED; ANGINA PECTORIS; ANGIOPLASTY, BALLOON, CORONARY; ANTICOAGULANTS; CHI-SQUARE DISTRIBUTION; COMBINED MODALITY THERAPY; FEMALE; HEMORRHAGE; HEPARIN; HIRUDINS; HUMANS; INCIDENCE; LOGISTIC MODELS; MALE; MYOCARDIAL INFARCTION; PEPTIDE FRAGMENTS; PROPENSITY SCORE; PROSPECTIVE STUDIES; RECOMBINANT PROTEINS; RISK FACTORS;

EID: 78049329504     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2010.06.047     Document Type: Article

References (25)

1. G.W. Stone, B.T. McLaurin, D.A. Cox, M.E. Bertrand, A.M. Lincoff, J.W. Moses, H.D. White, S.J. Pocock, J.H. Ware, F. Feit, A. Colombo, P.E. Aylward, A.R. Cequier, H. Darius, W. Desmet, R. Ebrahimi, M. Hamon, L.H. Rasmussen, H.J. Rupprecht, J. Hoekstra, R. Mehran, and E.M. Ohman Bivalirudin for patients with acute coronary syndromes N Engl J Med 355 2006 2203 2216
2. A.M. Lincoff, J.A. Bittl, R.A. Harrington, F. Feit, N.S. Kleiman, J.D. Jackman, I.J. Sarembock, D.J. Cohen, D. Spriggs, R. Ebrahimi, G. Keren, J. Carr, E.A. Cohen, A. Betriu, W. Desmet, D.J. Kereiakes, W. Rutsch, R.G. Wilcox, P.J. de Feyter, A. Vahanian, and E.J. Topol Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial JAMA 289 2003 853 863
3. A. Kastrati, F.J. Neumann, J. Mehilli, R.A. Byrne, R. Iijima, H.J. Buttner, A.A. Khattab, S. Schulz, J.C. Blankenship, J. Pache, J. Minners, M. Seyfarth, I. Graf, K.A. Skelding, J. Dirschinger, G. Richardt, P.B. Berger, and A. Schomig Bivalirudin versus unfractionated heparin during percutaneous coronary intervention N Engl J Med 359 2008 688 696
4. G.W. Stone, B. Witzenbichler, G. Guagliumi, J.Z. Peruga, B.R. Brodie, D. Dudek, R. Kornowski, F. Hartmann, B.J. Gersh, S.J. Pocock, G. Dangas, S.C. Wong, A.J. Kirtane, H. Parise, and R. Mehran Bivalirudin during primary PCI in acute myocardial infarction N Engl J Med 358 2008 2218 2230
5. H.D. White, E.M. Ohman, A.M. Lincoff, M.E. Bertrand, A. Colombo, B.T. McLaurin, D.A. Cox, S.J. Pocock, J.A. Ware, S.V. Manoukian, A.J. Lansky, R. Mehran, J.W. Moses, and G.W. Stone Safety and efficacy of bivalirudin with and without glycoprotein IIb/IIIa inhibitors in patients with acute coronary syndromes undergoing percutaneous coronary intervention 1-year results from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial J Am Coll Cardiol 52 2008 807 814
6. A.M. Lincoff, N.S. Kleiman, D.J. Kereiakes, F. Feit, J.A. Bittl, J.D. Jackman, I.J. Sarembock, D.J. Cohen, D. Spriggs, R. Ebrahimi, G. Keren, J. Carr, E.A. Cohen, A. Betriu, W. Desmet, W. Rutsch, R.G. Wilcox, P.J. de Feyter, A. Vahanian, and E.J. Topol Long-term efficacy of bivalirudin and provisional glycoprotein IIb/IIIa blockade vs heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary revascularization: REPLACE-2 randomized trial JAMA 292 2004 696 703
7. S. Schulz, J. Mehilli, G. Ndrepepa, F.J. Neumann, K.A. Birkmeier, S. Kufner, G. Richardt, P.B. Berger, A. Schomig, and A. Kastrati Bivalirudin vs. unfractionated heparin during percutaneous coronary interventions in patients with stable and unstable angina pectoris: 1-year results of the ISAR-REACT 3 trial Eur Heart J 31 2010 582 587
8. R. Mehran, A.J. Lansky, B. Witzenbichler, G. Guagliumi, J.Z. Peruga, B.R. Brodie, D. Dudek, R. Kornowski, F. Hartmann, B.J. Gersh, S.J. Pocock, S.C. Wong, E. Nikolsky, L. Gambone, L. Vandertie, H. Parise, G.D. Dangas, and G.W. Stone Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial Lancet 374 2009 1149 1159
9. C.P. Cannon, A. Battler, R.G. Brindis, J.L. Cox, S.G. Ellis, N.R. Every, J.T. Flaherty, R.A. Harrington, H.M. Krumholz, M.L. Simoons, F.J. Van De Werf, W.S. Weintraub, K.R. Mitchell, S.L. Morrisson, H.V. Anderson, D.S. Cannom, W.R. Chitwood, J.E. Cigarroa, R.L. Collins-Nakai, R.J. Gibbons, F.L. Grover, P.A. Heidenreich, B.K. Khandheria, S.B. Knoebel, H.L. Krumholz, D.J. Malenka, D.B. Mark, C.R. McKay, E.R. Passamani, M.J. Radford, R.N. Riner, J.B. Schwartz, R.E. Shaw, R.J. Shemin, D.B. Van Fossen, E.D. Verrier, M.W. Watkins, D.R. Phoubandith, and T. Furnelli American College of Cardiology key data elements and definitions for measuring the clinical management and outcomes of patients with acute coronary syndromes A report of the American College of Cardiology Task Force on Clinical Data Standards (Acute Coronary Syndromes Writing Committee) J Am Coll Cardiol 38 2001 2114 2130
10. American College of Cardiology National Cardiovascular Data Registry http://wwwaccncdrcom/WebNCDR/ELEMENTSASPX/ Accessed on March 17, 2010
11. S.C. Smith Jr, T.E. Feldman, J.W. Hirshfeld Jr., A.K. Jacobs, M.J. Kern, S.B. King III, D.A. Morrison, W.W. O'Neill, H.V. Schaff, P.L. Whitlow, D.O. Williams, E.M. Antman, C.D. Adams, J.L. Anderson, D.P. Faxon, V. Fuster, J.L. Halperin, L.F. Hiratzka, S.A. Hunt, R. Nishimura, J.P. Ornato, R.L. Page, and B. Riegel ACC/AHA/SCAI 2005 guideline update for percutaneous coronary interventionsummary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention) J Am Coll Cardiol 47 2006 216 235
12. S.B. King III, S.C. Smith Jr, J.W. Hirshfeld Jr., A.K. Jacobs, D.A. Morrison, D.O. Williams, T.E. Feldman, M.J. Kern, W.W. O'Neill, H.V. Schaff, P.L. Whitlow, C.D. Adams, J.L. Anderson, C.E. Buller, M.A. Creager, S.M. Ettinger, J.L. Halperin, S.A. Hunt, H.M. Krumholz, F.G. Kushner, B.W. Lytle, R. Nishimura, R.L. Page, B. Riegel, L.G. Tarkington, and C.W. Yancy 2007 Focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 51 2008 172 209
13. F.G. Kushner, M. Hand, S.C. Smith Jr, S.B. King III, J.L. Anderson, E.M. Antman, S.R. Bailey, E.R. Bates, J.C. Blankenship, D.E. Casey Jr, L.A. Green, J.S. Hochman, A.K. Jacobs, H.M. Krumholz, D.A. Morrison, J.P. Ornato, D.L. Pearle, E.D. Peterson, M.A. Sloan, P.L. Whitlow, and D.O. Williams 2009 Focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update) a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 54 2009 2205 2241
14. P. Rosenbaum The central role of propensity score in observational studies for casual effects Biometrika 70 1983 41 45
15. D. Rubin Using propensity score to help design observational studies: application to the tobacco litigation Health Serv Outcomes Res Methodol 2 2001 169 188
16. A. Ahmed, A. Husain, T.E. Love, G. Gambassi, L.J. Dell'Italia, G.S. Francis, M. Gheorghiade, R.M. Allman, S. Meleth, and R.C. Bourge Heart failure, chronic diuretic use, and increase in mortality and hospitalization: an observational study using propensity score methods Eur Heart J 27 2006 1431 1439
17. P.C. Austin Some methods of propensity-score matching had superior performance to others: results of an empirical investigation and Monte Carlo simulations Biomed J 51 2009 171 184
18. P.C. Austin, P. Grootendorst, and G.M. Anderson A comparison of the ability of different propensity score models to balance measured variables between treated and untreated subjects: a Monte Carlo study Stat Med 26 2007 734 753
19. J.Z. Ayanian, M.B. Landrum, E. Guadagnoli, and P. Gaccione Specialty of ambulatory care physicians and mortality among elderly patients after myocardial infarction N Engl J Med 347 2002 1678 1686
20. G. Ndrepepa, S. Schulz, D. Keta, J. Mehilli, A. Birkmeier, S. Massberg, K.L. Laugwitz, F.J. Neumann, M. Seyfarth, P.B. Berger, A. Schomig, and A. Kastrati Bleeding after percutaneous coronary intervention with bivalirudin or unfractionated heparin and one-year mortality Am J Cardiol 105 2010 163 167
21. E. Nikolsky, R. Mehran, G. Dangas, M. Fahy, Y. Na, S.J. Pocock, A.M. Lincoff, and G.W. Stone Development and validation of a prognostic risk score for major bleeding in patients undergoing percutaneous coronary intervention via the femoral approach Eur Heart J 28 2007 1936 1945
22. J.W. Eikelboom, S.R. Mehta, S.S. Anand, C. Xie, K.A. Fox, and S. Yusuf Adverse impact of bleeding on prognosis in patients with acute coronary syndromes Circulation 114 2006 774 782
23. S.V. Rao, K. O'Grady, K.S. Pieper, C.B. Granger, L.K. Newby, F. Van de Werf, K.W. Mahaffey, R.M. Califf, and R.A. Harrington Impact of bleeding severity on clinical outcomes among patients with acute coronary syndromes Am J Cardiol 96 2005 1200 1206 (Pubitemid 41505393)
24. T.D. Kinnaird, E. Stabile, G.S. Mintz, C.W. Lee, D.A. Canos, N. Gevorkian, E.E. Pinnow, K.M. Kent, A.D. Pichard, L.F. Satler, N.J. Weissman, J. Lindsay, and S. Fuchs Incidence, predictors, and prognostic implications of bleeding and blood transfusion following percutaneous coronary interventions Am J Cardiol 92 2003 930 935
25. F. Feit, M.D. Voeltz, M.J. Attubato, A.M. Lincoff, D.P. Chew, J.A. Bittl, E.J. Topol, and S.V. Manoukian Predictors and impact of major hemorrhage on mortality following percutaneous coronary intervention from the REPLACE-2 Trial Am J Cardiol 100 2007 1364 1369